As such, pharmacological agents that target the spike protein or host’s ACE2 proteins used to treat SARS and Middle-East Respiratory Syndrome (MERS) have been suggested as potential agents that could be used to treat patients with COVID-19. The gene discussed is ACE2; the disease is Middle East respiratory syndrome.